Statistics from Altmetric.com
Q Does the addition of behaviour therapy to continuing medication benefit people with obsessive-compulsive disorder who have responded to drug treatment?
Randomised controlled trial.
Follow up period:
University Medical Centre Utrecht, the Netherlands; October 1998 to June 2002.
Ninety six adult outpatients with DSM-IV obsessive-compulsive disorder (OCD) who had responded to three months of medication (⩾25% reduction in score on Yale-Brown Obsessive Compulsive Scale (Y-BOCS)) with venlafaxine (300 mg/day) or paroxetine (60 mg/day). Exclusion criteria: comorbid Axis I disorder during past six months; Hamilton Rating Scale for Depression score >16; and cognitive and/or behaviour therapy within six months of randomisation.
People were allocated to continuing drug treatment (300 mg/day venlafaxine or 60 mg/day paroxetine) plus behaviour therapy …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.